Table 2.
Demographic, clinical, laboratory, and procedural variables of patients (2)
| Variable | n | % |
| Sex | ||
| Female | 81 | 13.9 |
| Male | 501 | 86.1 |
| Disease type | ||
| No surgery | 371 | 63.7 |
| Recurrence after surgery | 211 | 36.3 |
| TACE history | 333 | 57.2 |
| History of abdominal pain after TACE | 73 | 12.5 |
| Pathological properties | ||
| HCC | 280 | 48.1 |
| ICC | 13 | 2.2 |
| Unknown | 265 | 45.5 |
| Other | 24 | 4.1 |
| Tumor size | ||
| ≤ 5 cm | 334 | 57.4 |
| > 5 cm | 248 | 42.6 |
| Number of tumors | ||
| ≤ 2 (non-multiple) | 197 | 33.8 |
| > 2 (multiple) | 385 | 66.2 |
| Invasion of blood vessels | 176 | 30.2 |
| Blank microsphere | 138 | 23.7 |
| PVA particles | 63 | 10.8 |
| Method of TACE | ||
| Traditional TACE | 336 | 57.7 |
| DEB-TACE | 246 | 42.3 |
| Prophylactic analgesics | ||
| Tenay | 74 | 12.7 |
| Kaffin | 112 | 19.2 |
| Dezocine | 252 | 43.3 |
| Pentam | 29 | 5 |
| None | 58 | 10 |
| Two painkillers | 57 | 9.8 |
| Pain after TACE | ||
| No pain/mild pain | 485 | 83.3 |
| Moderate pain/severe pain | 97 | 16.7 |
TACE: Transarterial hepatic chemoembolization; DEB-TACE: Transarterial chemoembolization with drug-eluting beads; HCC: Hepatocellular carcinoma; ICC: Intrahepatic cholangiocarcinoma; PVA: Polyvinyl alcohol.